Previous Article | Next Article 
Molecular and Cellular Biology, January 1999, p. 515-525, Vol. 19, No. 1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Fiber-Type-Specific Transcription of the Troponin I
Slow Gene Is Regulated by Multiple Elements
Soledad
Calvo,
Pratap
Venepally,
Jun
Cheng, and
Andres
Buonanno*
Unit on Molecular Neurobiology, National
Institute of Child Health and Human Development, National
Institutes of Health, Bethesda, Maryland 20892
Received 17 July 1998/Returned for modification 17 September
1998/Accepted 28 September 1998
 |
ABSTRACT |
The regulatory elements that restrict transcription of genes
encoding contractile proteins specifically to either slow- or fast-twitch skeletal muscles are unknown. As an initial step towards understanding the mechanisms that generate muscle diversity during development, we have identified a 128-bp troponin I slow upstream element (SURE) and a 144-bp troponin I fast intronic element (FIRE) that confer fiber type specificity in transgenic mice (M. Nakayama et
al., Mol. Cell. Biol. 16:2408-2417, 1996). SURE and FIRE have maintained the spatial organization of four conserved motifs (3' to
5'): an E box, an AT-rich site (A/T2) that binds MEF-2, a CACC site,
and a novel CAGG motif. Troponin I slow (TnIs) constructs harboring
mutations in these motifs were analyzed in transiently and stably
transfected Sol8 myocytes and in transgenic mice to assess their
function. Mutations of the E-box, A/T2, and CAGG motifs completely
abolish transcription from the TnI SURE. In contrast, mutation of the
CACC motif had no significant effect in transfected myocytes or on the
slow-specific transcription of the TnI SURE in transgenic mice. To
assess the role of E boxes in fiber type specificity, a chimeric
enhancer was constructed in which the E box of SURE was replaced with
the E box from FIRE. This TnI E box chimera, which lacks the SURE NFAT
site, confers essentially the same levels of transcription in
transgenic mice as those conferred by wild-type SURE and is
specifically expressed in slow-twitch muscles, indicating that the E
box on its own cannot determine the fiber-type-specific expression of
the TnI promoter. The importance of the 5' half of SURE, which bears
little homology to the TnI FIRE, in muscle-specific expression was
analyzed by deletion and linker scanning analyses. Removal of the 5'
half of SURE (
846 to
811) results in the loss of expression in
stably transfected but not in transiently expressing myocytes. Linker scanning mutations identified sequences in this region that are necessary for the function of SURE when integrated into chromatin. One
of these sites (GTTAATCCG), which is highly homologous to a
bicoid consensus site, binds to nuclear proteins from several mesodermal cells. These results show that multiple elements are involved in the muscle-specific activity of the TnIs promoter and that
interactions between upstream and downstream regions of SURE are
important for transcription in the context of native chromatin.
 |
INTRODUCTION |
Skeletal muscle commitment,
differentiation, and maturation are largely controlled by the
transcriptional regulation of genes encoding channels, receptors,
metabolic enzymes, and muscle-specific contractile proteins (8,
52). Whereas our understanding of the transcription factors
regulating the commitment and differentiation of myocytes has advanced
significantly in the past years, little is known about the factors that
regulate fiber type diversity during muscle maturation. During
postnatal development, following the innervation of muscles by
motoneurons, distinct isoforms of myosin heavy chains and other
contractile proteins accumulate in myofibers. These isoforms determine
the rates of force generation, the relaxation rates, and the
fatigability of the myofibers.
Transcription is the major regulatory mechanism known to restrict the
expression of genes encoding contractile proteins to specific types of
muscle fibers during development. Thus, one approach to understanding
the molecular mechanisms controlling muscle diversification and
plasticity is to identify the DNA regulatory sequences that confer
fiber-type-specific expression of contractile protein genes. Toward
this end, we have used the regulation of troponin I (TnI) genes as a
model to elucidate the mechanisms that generate fiber diversification.
In the adult, three troponin isoforms, which are presumed to have
originated from a common ancestral gene, are specifically expressed in
slow (TnIs), fast (TnIf), and cardiac (TnIc) muscles (28).
The different isoforms of TnI, in combination with troponins C and T,
participate in the formation of a complex that is involved in the
regulation of calcium-mediated interactions during muscle contraction
(63). As with many other skeletal muscle-specific genes,
transcription of TnI genes is initially activated during myoblast
differentiation (3, 12, 34, 61). Embryonic and fetal
myofibers coexpress the TnIs and TnIf isoforms, but as muscles are
innervated by motoneurons and mature, expression of the slow- and
fast-muscle genes is confined to type I and II fibers, respectively
(27).
We have previously used transfected myocyte cell cultures to identify
regions in the TnIs gene that are important for its regulation in the
differentiated myotubes (3). Subsequently, somatic gene
transfer experiments performed in rats as well as analyses using
transgenic mice identified a slow upstream regulatory element (SURE) in
human (13) and rat (43) TnIs genes that specifically confers expression to slow-twitch muscles and a fast intronic regulatory element (FIRE) in the quail TnIf gene that directs
transcription in fast-twitch muscles (43). Comparison of
these elements identified four spatially conserved motifs: an E box, an
AT-rich site, a CACC element, and a CAGG motif, of which the first
three are also found in numerous other regulatory regions of genes
encoding skeletal muscle proteins. The E box interacts with various
skeletal muscle-specific regulatory factors of the basic
helix-loop-helix (bHLH) family such as MyoD (15), myogenin
(19, 59), myf-5 (5), and MRF-4 (6, 41,
48), which have been shown to be important for activating
transcription of muscle genes during myogenesis and differentiation
(7, 20, 58). The AT-rich site binds MEF2/RSRF factors that
are more widely expressed than the myogenic bHLH factors and which are important for the regulation of muscle genes encoding structural proteins and transcription factors (18, 24, 29, 46, 49, 60).
The importance of the CACC element in the transcription of muscle genes
is not clear, although a cDNA encoding a novel winged-helix protein
binding to the CACC/SP1 motif was recently isolated from mouse
(4). The CAGG motif present in the TnIs and TnIf enhancers
has not been described previously, but a similar site, known as a MEF-3
site, has been found in many other muscle promoters (29,
44).
Since these sites are conserved in both TnI SURE and FIRE, which direct
slow- and fast-fiber-type-specific transcription, respectively, it is
possible that these sites are important only for their early
developmental expression during myogenesis and differentiation.
However, these sites may also play a critical role in the slow- and
fast-fiber-type-specific expression of troponins in the mature muscle
by their interaction with fiber-specific transcription factors.
Alternatively, the nonhomologous sequences in SURE and FIRE may harbor
elements responsible for the restriction of TnIs and TnIf gene
expression to the slow and fast adult muscle, respectively. Thus, to
address these possibilities, we have performed transcriptional analyses
with constructs containing mutated TnIs promoter fragments as well as a
chimeric enhancer containing sequences from both SURE and FIRE in
myotube cell cultures and transgenic mice. Since muscle cells in
culture serve as excellent models to study gene regulation during
development but fail to manifest the specific contractile properties of
adult muscles, we have used myotube cell cultures and transgenic mice
to study different aspects of TnI regulation. While analyses in cells
have allowed us to characterize DNA sequences that regulate the
tissue-specific and developmental induction of the TnIs gene, studies
with transgenic mice enabled the identification of
cis-acting sequences that confer fiber-specific
transcription. Based on these studies, we present evidence in this
paper that of the four conserved motifs present in SURE, the E-box,
MEF-2, and CAGG sites are indispensable for developmental as well as
fiber-specific transcription of the rat TnIs gene and that the
substitution of the E box in SURE with a similar sequence present in
FIRE does not alter the ability of the TnIs promoter to direct
slow-fiber-specific expression in the adult muscle.
 |
MATERIALS AND METHODS |
Cells and transfections.
Sol8 myoblasts (42) were
grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with
20% fetal bovine serum and antibiotics (200 U of penicillin per ml and
200 µg of streptomycin per ml). For transient transfections, Sol8
cells were plated in six-well tissue culture dishes at a density of
2 × 105 cells per well. The next day, DNA-calcium
phosphate precipitates (25) were added directly to the
culture medium. After 16 to 20 h, cells were washed twice with
phosphate-buffered saline (PBS) and transferred into differentiation
medium (DMEM supplemented with 5% horse serum). Cells in each well
were cotransfected with 2.5 µg of luciferase reporter plasmid and 0.1 µg of pRL-SV40 (Promega). For stable transfections, 106
cells per 10-cm-diameter dish were plated and cotransfected with 10 µg of reporter construct and 2 µg of a plasmid conferring
hygromycin resistance (pHyg) (56) by using the DNA-calcium
phosphate technique. Cells were replated 24 h later, and
hygromycin (Sigma) was added the next day to the growth medium at a
concentration of 300 µg/ml. Following 3 or 4 weeks of selection,
pools of resistant colonies were replated, and 2 days later they were
transferred to differentiation medium. Both transient- and stably
transfected Sol8 myotubes were harvested 72 h after being switched
to the differentiation medium.
Plasmids.
All the reporter constructs were made by using
either the promoterless pCAT Basic or pGL3 Basic vectors from Promega.
Plasmids TnIs500CAT and TnIs500SURECAT as well as plasmids harboring
point mutations in the core motifs (A/T1, CAGG, CACC, A/T2, and E box) of SURE have been described previously (9, 43). The 500-bp upstream sequence of the TnIs gene was also cloned into
SmaI-cleaved pGL3 Basic vector to generate TnIs500LUC.
The recombinant PCR method (30) was used to generate E box
Chimera, a SURE-FIRE chimeric construct in which the sequence
868 to
759 in SURE is fused 5' to positions +664 to +633 of the FIRE
sequence and cloned into the SstI-NheI-cleaved
plasmid Tn500LUC. The plasmid TnIs95LUC was generated by cloning a PCR fragment containing a 95-bp upstream sequence of the rat TnIs gene into
the XhoI-HindIII-cleaved pGL3 Basic vector.
SURE, FIRE, and two deletion mutants lacking the sequences
868 to
778 from SURE and +776 to +703 from FIRE, respectively, were also
amplified by PCR and subcloned into the
SstI-NheI-cleaved plasmid TnIs95LUC to generate
the constructs TnIs95SURELUC, TnIs95FIRELUC, SURE
868/
778, and
FIRE
+776/+703, respectively. All the constructs generated by PCR
were verified by sequencing.
Mutation of SURE by linker scanning.
By using asymmetric PCR
and a single mutant primer (45) the 5' half of SURE was
mutated 6 bp at a time with an EcoRI site (GAATTC).
The final PCR products were subcloned into the
SstI-NheI-cleaved plasmid Tn500LUC and verified
by sequencing.
Transgenic mice.
The isolation of fragments for the
injection of embryos to generate transgenic mice was performed
essentially as described previously (3, 43). The
chloramphenicol acetyltransferase (CAT) reporter plasmids Tns500A/T1,
Tns500CAGG, Tns500CACC, and Tns500Ebox were digested with
HindIII and BamHI to isolate a fragment containing specific TnI sequences linked to the CAT reporter gene plus
the simian virus 40 (SV40) large t-antigen intron and polyadenylation site. Two of the four Tns500CACC lines and three of the four Tns500Ebox transgenic mice generated were also described previously
(43). The plasmid Ebox Chimera was digested with
SstI and BamHI to isolate a fragment containing
specific TnI sequence linked to the luciferase reporter gene plus SV40
late poly(A) signal. To prepare DNA for microinjection, constructs were
digested to remove plasmid sequences, electrophoretically purified on
agarose gels, electroeluted, and purified with ELUTIP-D columns
(Schleicher & Schuell). Transgenic mice were prepared by previously
described methods (31). Mice were generated, and the
subsequent lines were propagated in an FVB/N background. Putative
founders and their offspring were screened by Southern or slot blot
analysis of tail DNA by using a CAT or luciferase probe. Adult
transgenic mice were used to analyze tissue- and muscle-type-specific
expression of CAT or luciferase activity. A variety of tissues
including brain, liver, kidney, and heart as well as skeletal muscles
from the body wall, intercostal area, diaphragm, tongue, and hind limbs
were collected for the preparation of extracts. Since the reporter
activity was restricted to skeletal muscles, only the extracts prepared
from the hind-limb crural muscles of transgenic mice were analyzed.
Analysis of CAT and luciferase activities.
Sol8 cell
extracts for CAT analysis were prepared by resuspending the collected
cells in 100 µl of 0.25 M Tris-HCl (pH 8) and repeated
freeze-thawing. Transgenic mouse tissue extracts were prepared
essentially as described previously (17). Briefly, the
tissues were sonicated in 0.25 M Tris-HCl (pH 8.0) containing 0.5 mM
AEBSF [4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochlorine], 2 mg
of leupeptin/ml, 2 mg of aprotinin/ml, and 1 mg of pepstatin A/ml for
10 s with a Branson Sonifier 450 (microtip setting, 5; 50%
efficiency). The homogenates were centrifuged at 12,000 × g for 10 min at 4°C, and the supernatants were collected
for analysis. For each sample, the protein concentration was determined
by the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, Ill.) with bovine serum albumin (BSA) as the standard. The CAT assays (23) were performed with the supernatants at 37°C for 1 or
3 h. The reaction products were separated by thin-layer
chromatography and were quantitated with a Molecular Dynamics PhosphorImager.
To assay for luciferase activity, Sol8 myotubes were washed once with
PBS and harvested with Promega passive lysis buffer.
The
Dual-Luciferase Reporter Assay System (Promega) was used to
measure
luciferase and
renilla activity with a Berthold luminometer.
For analysis of transgenic mice, tissues were collected in liquid
nitrogen, pulverized, and immediately homogenized in Promega lysis
buffer plus protease inhibitors (Complete Protease Inhibitor Cocktail;
Boehringer Mannheim). Luciferase activity in the extracts was
normalized for the
renilla activity in the case of
transiently
transfected cells and for protein concentration in the case
of
both stably transfected cells and tissues isolated from transgenic
mice.
Electrophoretic mobility shift assays (EMSAs).
The
double-stranded complementary oligonucleotides of the following
sequences were used in the electrophoretic mobility shift assays (the
EcoRI [GAATTC] mutant sequences are shown in
boldface): SURE
850/
808WT, 5'-ATA ATA GCT ACC GGA TTA ACA TAG CAG
GCA TTG TCT TTC TCT G-3'; SURE
850/
808LS#3, 5'-ATA AGA ATT
CCC GGA TTA ACA TAG CAG GCA TTG TCT TTC TCT G-3'; SURE
850/
808LS#4, 5'-ATA ATA GCT AGA ATT CTA ACA TAG CAG GCA
TTG TCT TTC TCT G-3'; SURE
850/
808LS#5, 5'-ATA ATA GCT ACC GGA
TGA ATT CAG CAG GCA TTG TCT TTC TCT G-3'; SURE
850/
808LS#6, 5'-ATA ATA GCT ACC GGA TTA ACA TGA ATT CCA
TTG TCT TTC TCT G-3'; SURE
850/
808LS#7, 5'-ATA ATA GCT ACC GGA TTA
ACA TAG CAG GGA ATT CCT TTC TCT G-3'; SURE
850/
808LS#8,
5'-ATA ATA GCT ACC GGA TTA ACA TAG CAG GCA TTG TGA ATT CCT
G-3'; SURE
842/
815, 5'-TAC CGG ATT AAC ATA GCA GGC ATT GTC T-3';
SURE
844/
827, 5'-GCT ACC GGA TTA ACA TAG-3'; SURE
832/
815,
5'-ACA TAG CAG GCA TTG TCT-3'.
Nuclear extracts from Sol8 myoblasts and myotubes as well as from
HepG2, 3T3, and rat cerebellar granule cells were prepared
by the
method of Dignam et al. (
16) and modified according to
the
procedure described by Ausubel et al. (
2). Whole-tissue
extracts from rat soleus (SOL) and extensor digitorium longus
(EDL)
muscles were prepared by the sonication of tissues essentially
as
described by Kornhauser et al. (
35). Protein concentrations
were determined by BCA assay (Pierce) with BSA as a standard.
For
EMSAs, the double-stranded oligonucleotides were labeled with
polynucleotide kinase and [

-
32P]dATP (6,000 Ci/mmol;
NEN). Five to ten micrograms of nuclear
extract obtained from various
cell lines or 100 µg of whole-tissue
extracts from rat muscle was
mixed with binding buffer (20 mM
HEPES [pH 7.9], 50 mM KCl, 4 mM
MgCl
2, 4% Ficoll, 5% glycerol,
0.2 mM EDTA, 0.5 mM
dithiothreitol, 2 µg of poly(dI-dC), and
32P-labeled
probe (10,000 cpm) and incubated on ice for 15 min.
For the competition
assay, 10 pmol of unlabeled competitor oligonucleotide
was used along
with the labeled probe. The DNA-protein complexes
were resolved by
electrophoresis at 4°C on a 5% polyacrylamide-2.5%
glycerol gel in
0.5× Tris-borate-EDTA buffer (
51) and visualized
by
autoradiography.
 |
RESULTS |
TnIs and TnIf reporter constructs.
We have previously
identified a SURE in the rat TnIs gene that is necessary to convey
slow-twitch muscle specificity and a FIRE from the quail TnI gene that
confers expression in fast-twitch muscles (9, 43). Sequence
comparison of these two elements revealed the presence of four
conserved motifs, namely, an E box, an AT-rich site (A/T2), a CACC
site, and a novel site we called CAGG. An additional AT-rich motif,
which we denoted A/T1, is conserved within the SUREs of the rat and
human TnIs genes but is not present in the FIRE sequence of the quail
TnIf gene (Fig. 1). In the present study,
we have generated mutant TnIs reporter constructs to evaluate the
functional role of these conserved motifs in transfected cultured myocytes and transgenic mice. In addition, a chimeric enhancer construct, denoted Ebox Chimera, in which the E-box element of SURE is
replaced with the corresponding sequence from FIRE, was generated (Fig.
1) to analyze the role of E-box motifs in the fiber-type-specific
expression of the TnIs promoter. The complete sequences of both SURE
and FIRE were previously published (9, 43).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Organization of the TnIs reporter constructs used in the
studies. A schematic diagram of the 5' flanking region of the TnIs gene
is shown at the top. (A) TnIs reporter constructs used for cell
transfections and the generation of transgenic mice. TnIs500 contains
479 bp of the TnIs promoter inserted upstream of either the CAT or the
luciferase reporter coding sequence. TnIs500SURECAT and TnIs500SURELUC
were constructed by the insertion of the 128-bp SURE fragment ( 868 to
741) into the TnIs500 reporter. TnIs95LUC contains 95 bp of the basal
TnIs promoter upstream of the luciferase reporter coding sequence,
TnIs95SURE and TnIs95FIRE were generated by the insertion of SURE and
the 144-bp FIRE fragment (+776 to +663 of quail TnIf intronic
sequence), respectively, upstream of the TnIs95LUC basal promoter. The
deletion constructs TnIs95SURE  868/ 778 and TnIs95 FIRE
+776/+703 were made by PCR amplification of fragments 778 to 741
of SURE and +703 to +633 of FIRE, respectively, and subsequent
insertion into the SstI-NheI-cleaved TnIs95LUC.
(B) Schematic representation of the SURE-FIRE TnI E-box Chimera
construct. Ebox Chimera was made by using the PCR ligation technique as
described in Materials and Methods. The 868 to 759 sequence of SURE
was joined to the +664 to +633 sequence of FIRE and inserted 5' of the
luciferase reporter. Open boxes, FIRE sequences; shaded boxes, SURE
sequences.
|
|
Transcriptional analysis of the conserved SURE motifs in stably
transfected myocytes.
The mouse C2C12 and Sol8 cell lines have
provided an excellent system for studying muscle-specific gene
regulation during myocyte differentiation. In most instances, these
cells faithfully recapitulate the pattern of gene regulation observed
in primary cell cultures of mammalian muscle and express a battery of
skeletal-muscle-specific genes. The genes encoding TnIs and TnIf
isoforms are not expressed in the undifferentiated myoblasts. However,
their expression is quickly induced within 24 h after the transfer
of myoblasts into differentiation medium that contains reduced levels
of growth factors (3, 28). We had previously shown that CAT
reporter constructs containing a 500-(TnIs500) or 250 (TnIs250)-bp
upstream region of the TnIs gene conferred low levels of
cell-type-specific transcription in transiently transfected C2C12
myoblasts (3). However, as shown in Fig.
2, the TnIs500 construct is inactive when
stably transfected into Sol8 myocytes. This result is consistent with
the observations made previously with transgenic mice where both
TnIs500 and TnIs250 promoters failed to direct reporter gene expression
in embryonic, fetal, and adult muscles (43). The addition of
the 128-bp SURE to the TnI500 promoter increased transcription by
approximately threefold in transiently transfected cells
(9). More importantly, it restored the ability of the
TnIs500 promoter to direct transcription in stably transfected cell
lines (Fig. 2) and in transgenic mice (43). Since the
results obtained from the stable transfections paralleled those
observed with transgenic mice, we have chosen the former as our initial
assay for examining the functional significance of the conserved SURE
motifs in the muscle-specific expression of the TnIs gene.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Mutational analysis of the conserved sites of SURE in
stably transfected Sol8 myocytes. The transcriptional activities
conferred by constructs harboring distinct mutations in each of the
conserved motifs in TnI SURE were analyzed in stably transfected Sol8
myotubes. The levels of CAT reporter activity were measured in
whole-cell extracts prepared from cells transfected with the A/T1,
CAGG, CACC, A/T2, and E-box mutant constructs and compared to reporter
levels conferred by the wild-type TnIs500SURE construct. The wild-type
sequences from each of these motifs, and the mutations made therein,
are shown at the bottom. For each construct, two independent DNA
preparations were used to make the CaPO4 precipitates, and
a total of six pools of stably transfected myotubes were analyzed per
construct. The extracts (50 µg) were assayed for CAT activity at
37°C for 3 h under conditions of linear enzymatic activity. The
values shown are means, and error bars indicate standard deviations.
|
|
Nuclear proteins from differentiated myotubes have been shown to bind
the conserved A/T1, CACC, and A/T2 motifs in TnI SURE
(
9)
and the E-box sequence in TnI FIRE (
39). Supershift
experiments
with antibodies have demonstrated that myogenic bHLH
factors bind
E box and MEF-2 binds to the A/T2 site (
9,
39,
43). To
test the functional importance of the five conserved
motifs, each
of these sites was mutated in the context of TnIs500SURE
(Fig.
2) and reporter constructs were stably transfected into Sol8
cells.
As shown in Fig.
2, mutation of either the A/T2 site or the E
box completely abolished the function of the TnI SURE in the Sol8
myotubes, while mutation of the CAGG motif reduced enhancer activity
by
70% relative to that of the wild-type element. In contrast,
mutations
of either the A/T1 or CACC motif had no significant
effect on reporter
expression in the stably transfected cells.
Thus, both the E box and
A/T2 motif, which were found to bind
the myogenic bHLH factors and
MEF-2, respectively, are absolutely
required for the function of SURE
during myoblast
differentiation.
Mutations in the conserved motifs affect SURE function in
transgenic mice.
Since mammalian muscle cells in culture fail to
mature and manifest fiber-type-specific properties, transgenic mice
were used to study the functional requirement of the conserved TnI SURE motifs in specifically directing transcription in slow-twitch muscles.
A total of 17 independent transgenic mouse lines were generated to
study different mutations, and in all cases at least four independent
"tail-positive" lines (i.e., DNA was successfully integrated into
the genome) were analyzed for each construct (Fig. 3). The data obtained from hind-limb
crural muscles, which include the slow-twitch (SOL) and the fast-twitch
tibialis (TAS), gastrocnemius (GAS), and EDL muscles, from independent
lines of mice are shown separately in Fig. 3. The muscles were
collected from 6- to 8-week-old mice since the maturation of muscles
and the manifestation of fiber-type-specific properties develop by 3 to
4 weeks of age.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of the effects of mutations in the conserved
sites of SURE in muscles of transgenic mice. CAT analyses were
performed on extracts made from different muscles on transgenic mice.
Independent transgenic mouse lines (indicated by number at the bottom
of each bar graph) were generated with the wild-type TnIs500SURE
fragment and fragments harboring mutations in the conserved A/T1, CAGG,
CACC, and E-box motifs (see Fig. 2). The CAT assays were performed with
100 µg of extract at 37°C for 3 h under conditions of linear
enzymatic activity. Since the values for CAT activities in the extracts
of transgenic line 7575 of TnIs500SURE and 8764 of CACC were very high
in relation to those of the other lines, these results are shown on a
different scale.
|
|
We have previously demonstrated that all three of the transgene lines
harboring the TnI500SURECAT construct exhibited reporter
activity
specifically in slow-twitch muscles (
43), and recently
we
found that three of four lines made with TnIs95SURELUC also
showed the
same specificity (data not shown). Thus, six of the
seven tail-positive
transgenic mouse lines expressed either CAT
or luciferase activity when
driven by the wild-type SURE. This
is consistent with the expected
frequency of expression in tail-positive
mice, because the transgene
fragment integrates 10 to 15% of the
time into heterochromatin and
fails to express (
31). As shown
in Fig.
3, none of the four
transgenic lines harboring mutations
in the SURE E box have detectable
CAT reporter activity in any
of the muscles tested. These results are
consistent with experiments
performed with both transiently
(
9) and stably (Fig.
2) transfected
myocytes. Similar
results were also obtained for transgenes that
carried the mutated SURE
CAGG motif. In this case, none of the
five lines exhibited CAT reporter
activity in any of the muscles
tested (Fig.
3). These results are in
agreement with those obtained
with the stably transfected Sol8 cells,
where this mutation was
found to diminish CAT reporter activity by
70%. Since mutations
in the A/T2 site were completely detrimental to
the SURE activity
in the stably transfected Sol8 myocytes, we have not
analyzed
its effects on promoter expression in transgenic mice.
However,
mutations in the A/T1 motif, unlike in the stably transfected
Sol8 myocytes, had a negative effect on the function of SURE in
transgenic mice. Only one of four transgenic lines expressed the
reporter, and as is the case for the wild-type SURE, CAT activity
was
restricted to the slow-twitch SOL (Fig.
3). The CACC mutation
showed
the least effects on TnI SURE function as three of the
four transgenic
lines expressed CAT preferentially in the slow-twitch
SOL (Fig.
3).
Thus, our results show that most of the conserved
motifs in the TnI
SURE are important for directing transcription
in adult skeletal
muscle. However, from these analyses we could
not determine if any of
these sites also had the ability to direct
slow-muscle-specific
expression. Since the role of myogenin bHLH
factors in generating
muscle diversity has been a matter of controversy
(
8), we
have generated a TnI SURE-FIRE chimera enhancer to
examine the
involvement of the E-box motif in the determination
of fiber-specific
expression of the TnI genes (see
below).
E-box and NFAT sequences in SURE do not determine fiber type
specificity.
We have exploited the fact that the linear
arrangement of the four motifs is conserved in both SURE and FIRE to
generate chimeric enhancer constructs. Using this approach, we have
analyzed the role of E boxes in the determination of the
fiber-type-specific transcription of the TnIs gene. As shown in Fig. 1,
the construct Ebox Chimera was made by replacing the E box (plus
flanking sequences) from SURE with the FIRE E-box sequence, a process
which also results in the removal of the NFAT site (10) from
the SURE. The experiments presented earlier established that the SURE E
box is completely indispensable for enhancer function as tested in
either transiently or stably transfected myocytes and in transgenic
mice (Fig. 2 and 3) (9). For this reason, the TnI Ebox
Chimera was initially tested in transfected Sol8 myotubes where it was
found to be as active as the wild-type TnI SURE (data not shown). These
results indicate that the FIRE E box can functionally substitute for
the SURE E box. To test if the E-box elements were directly involved in
the fiber-specific expression of the TnI promoter, six independent transgenic lines were generated with the TnI Ebox Chimera fragment. As
shown in Fig. 4, in five of the six
transgenic lines the E-box chimera enhancer conferred higher levels of
transcription in slow-twitch muscle (SOL) than in the fast-twitch EDL,
GAS, and TAS muscles; one line did not express the transgene. The
relative levels of reporter activities in different muscles of the Ebox
Chimera transgenic mice were indistinguishable from those in the mice
harboring the wild-type TnI SURE. These results demonstrate that, even
though the FIRE E box functionally substitutes for the E box in SURE, the TnIf E box is not sufficient to redirect transcription to fast-twitch fibers. In addition, the absence of the NFAT site in the
chimera construct does not affect slow-twitch-specific activity of the
enhancer. To our knowledge, this constitutes the first direct
demonstration that the E-box motif, although essential for
transcriptional activity of many muscle genes, does not determine the
fiber-type-specific expression of skeletal muscle genes.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
The E box from FIRE functionally substitutes for the
SURE E box but does not change the fiber-type specificity of TnI SURE.
Transgenic mouse lines were generated with a fragment from the TnI Ebox
Chimera construct, in which the E box from SURE was swapped for the
FIRE E box (Fig. 1). Luciferase activities assayed in extracts made
from different hind-limb muscles of five TnI Ebox Chimera transgenic
lines were normalized for protein concentration. The sequence of the
TnI Ebox Chimera construct, at the boundary between SURE (shaded box)
and FIRE (open box), is shown at the bottom; the E-box and A/T-2 motifs
are shown in boldface.
|
|
The upstream half of SURE is required for transcription in stable
transfectants.
The rat and human TnI SUREs share over 85%
homology throughout the entire 128-bp enhancer (9), while
homology with the quail TnI FIRE is mostly limited to the four
conserved motifs. Although the cis-acting elements present
in the downstream halves of SURE (9) and FIRE
(39) have been characterized, not much is known about the
regulatory sequences in the 5' end of SURE, which exhibits little
homology to FIRE. Hence, we were interested in determining the
functional importance of sequences residing in the 5' region of the TnI
enhancers. As shown in Fig. 5, the constructs SURE
868/
778 and FIRE
+776/+703, which lack all the sequences upstream of the A/T2 and E-box elements in SURE and FIRE,
respectively (see Fig. 1), reduce transcription levels by approximately
30% in the transiently transfected Sol8 myotubes (Fig. 5A). In stark
contrast, these constructs completely fail to activate transcription in
the stably transfected myotubes (Fig. 5B), suggesting that the upstream
elements within SURE and FIRE are essential for enhancer function when
integrated into chromatin.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
The 5' halves of SURE and FIRE are important for
transcriptional activity in stably transfected Sol8 myotubes. The
transcriptional activities conferred by the constructs TnI95 (negative
control), TnI95SURE (positive control), SURE  868/ 778 (5' half
deleted), and FIRE +776/+703 (5' half deleted) (see Fig. 1) were
analyzed in transiently (A) and stably (B) transfected Sol8 myotubes.
The luciferase reporter activities assayed in the extracts were
normalized either to renilla activity expressed from an
internal control plasmid (transient transfections) or for protein
concentration (stable transfections). Values are means (n 6); error bars indicate standard deviations.
|
|
The upstream region of SURE binds nuclear factors that are not
restricted to muscle cells.
Sequences in the downstream halves of
the rat TnI SURE (9) and the quail TnI FIRE (39),
extending from the CACC sites to the E boxes, have been shown to bind
nuclear factors from Sol8 and 23A2 myofiber cells, respectively. The
myogenic bHLH factors bind to the E box, MEF-2 binds to the A/T2 site,
and the binding pattern observed with the CACC site is similar to that
seen with the myoglobin CACC which binds to Sp1, CB40, and the
winged-helix myocyte nuclear factor-1 (4). We had previously
shown that the A/T1 site present in the upstream region of SURE bound
to factors present in Sol8 myotube nuclear extracts (9). In
this study, because of their importance for the expression of the TnIs promoter in stably transfected myocytes (Fig. 5B), we have analyzed the
sequences between
850 and
808 of SURE for their ability to interact
with the nuclear proteins present in different cell lines and tissues.
A 32P-labeled double-stranded oligonucleotide that includes
the sequence between
850 to
808 has been used as the wild-type
control (SURE
850/
808WT). A series of six oligonucleotides, each
with a 6-bp nested EcoRI site mutation, spanning the
sequence between
850 and
808 (from SURE
850/
808LS#3 to SURE
850/
808LS#8), were generated to identify the sequences involved in
interaction with the nuclear proteins. As seen from the EMSAs performed
with Sol8 myotube nuclear extracts (Fig.
6A), the wild-type SURE
850/
808WT sequence bound two prominent complexes, I and II. However, the faster-moving complex II seems to be nonspecific in nature since the
appearance of this band is not affected by any of the mutations that
were introduced along the length of the probe sequence (Fig. 6A, SURE
850/
808LS#3 to SURE
850/
808LS#8). In contrast, complex I is
formed as a result of specific interactions and requires sequences
between
840 and
827 of SURE, since only mutations that alter this
region in the wild-type oligonucleotide prevented its formation in the
presence of Sol8 nuclear extracts (Fig. 6A, SURE
850/
808LS#4 and
SURE
850/
808LS#5). The involvement of the sequences between
840
and
829 of SURE in the formation of complex I is also evident from
the observation that only the sequence between
844 and
829 (SURE
844/
827), in contrast to the oligonucleotide containing the CAGG
motif (SURE
832/
815), is able to compete for the complexes formed
by SURE
842/
815 in Sol8 myotube nuclear extracts (Fig. 6B).
Interestingly, as described in the next section, the sequence that is
responsible for the formation of complex I is also found to be
necessary for the expression of SURE in Sol8 myocytes (Fig.
7B, TnIsLS#4 and TnIsLS#5). Comparison of this sequence to known cis elements in the GCG transcription
factor database identified a site with a strong consensus
(GTTAATCCG) to the Drosophila bicoid binding site
(55). To examine the tissue-specific expression of the
nuclear factor(s) that bound to this sequence, EMSAs with the SURE
sequence from
842 to
815, which contained both the consensus bicoid
element and the CAGG motif, were performed with nuclear and whole-cell
extracts obtained from various cell lines and tissues. These included
mesodermally derived Sol8 myocytes, 3T3 fibroblasts, endodermally
derived hepatoma HepG2 cells, the ectodermally derived cerebellar
granule cells, and the rat SOL (slow-twitch) and EDL (fast-twitch)
muscles. As shown in Fig. 6B, binding to the consensus bicoid sequence
was not restricted to the extracts from the differentiated Sol8
myocytes and SOL, and EDL muscle fibers but was also found in the
nuclear proteins from undifferentiated myoblasts and HepG2 and 3T3
cells. However, the cerebellar granule cells, except for a minor
complex, lacked this binding activity, indicating that the factor(s)
involved in the interaction with the bicoid site of SURE, even though
present in the nonmuscle cells of mesodermal and endodermal origin, is not ubiquitous. A predominant faster-moving bicoid site binding complex
is observed in the muscle extracts compared with the HepG2 and 3T3
extracts (Fig. 6B). However, this complex is equally abundant in both
SOL and EDL muscles, suggesting that it may not be involved in the
fiber-specific transcription of the TnI genes.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 6.
EMSAs of nuclear protein binding to SURE upstream
sequences. (A) Sequences between 840 and 829 of SURE interact with
nuclear extracts from Sol8 myotubes. 32P-labeled
double-stranded oligonucleotides with the wild-type sequence (SURE
850/ 808WT) and GAATTC linker mutations (SURE
850/ 808LS#3 to SURE 850/ 808LS#8) are shown at the top (dashes
indicate sequence identities between the wild-type and mutant
oligonucleotides). The probe oligonucleotides were incubated on ice in
the absence ( ) or in the presence (+) of 5 µg of nuclear extracts
from Sol8 myotubes. The positions of complexes I and II are indicated
on the left. (B) The complexes that bind the 840 and 829 sequence
are not restricted to muscle cells. Sequences of the SURE 842/ 815,
SURE 844/ 827, and SURE 832/ 815 oligonucleotides used in the
EMSAs are shown at the top. Nuclear extracts (10 µg) from
undifferentiated Sol8 myoblasts (MB), differentiated Sol8 myotubes
(MT), HepG2 hepatoma cells, 3T3 fibroblasts, and cerebellar granule
cells (CGN), as well as whole-tissue extracts (100 µg) from SOL and
EDL hind-limb skeletal muscles were incubated with the
32P-labeled SURE 842/ 815 oligonucleotide and analyzed
as described above. For competition assays, a 100-fold molar excess of
unlabeled SURE 842/ 815, SURE 844/ 827, or SURE 832/ 815 was
used. The SOL and EDL lanes were exposed to X-ray film for 72 h,
and the other lanes were autoradiographed for 24 h.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
Linker scanning mutations through the 5' end of TnI
SURE. An EcoRI recognition sequence (GAATTC) was
used to generate a series of linker scanning mutations in the upstream
region of SURE (TnIsLS#3 to TnIsLS#9). Dashes indicate sequence
identities between the wild-type and the mutant oligonucleotides. These
constructs and wild-type TnIs500SURE were used to transfect Sol8
myocytes. Luciferase reporter activities were assayed in extracts made
from Sol8 myotubes and normalized either for the renilla used as an
internal control in the transient transfections (A) or for protein
concentration in the stable transfections (B). Values are means
(n 6); error bars indicate standard deviations.
|
|
Sequences necessary for SURE function are identified by linker
scanning mutations.
The effects of the series of progressive 6-bp
mutations, which correspond to the sequences used in the EMSAs
described above, were tested for SURE function in transfected myocytes.
As shown in Fig. 7, mutations in the sequences residing between
846
and
811 only moderately reduced luciferase activity in transiently transfected myotubes. However, the same mutations caused a more dramatic decrease in TnIs promoter expression in the stably transfected cells (Fig. 7B). In the transiently transfected myotubes, the linker
scanning mutations LS#3 to LS#8 reduced reporter activity to between 30 to 50% of that of the levels observed with the wild-type TnI SURE. In
contrast, mutations LS#3 to LS#8 reduced the levels of reporter gene
expression to less than 10% of the levels seen in the cells
transfected with the TnI SURE construct. The linker scanning mutation
TnsLS#6, which covers the core of the CAGG motif in addition to the
upstream flanking bases, was more effective in reducing reporter levels
than the point mutations restricted exclusively to the CAGG core (see
Fig. 2). Not all the sequences in this region are essential for
enhancer function. The construct harboring the LS#9 mutation, mapping
to a site located between the CAGG and CACC motifs, conferred
approximately 80% of the wild-type activity expressed in stably
transfected myotubes. These results corroborate those obtained from the
deletion experiments (Fig. 5B), demonstrating the importance of the 5'
sequences for the enhancer activity of SURE in stably transfected
myotubes, and suggest that cooperation between the upstream and
downstream sequences of SURE is essential for transcription of the TnIs
gene in its chromosomal context.
 |
DISCUSSION |
Transcriptional analyses presented in this study demonstrate that
multiple sequence elements present within SURE determine the early
developmental as well as the slow-fiber-type-specific activity of the
TnIs promoter. Of these elements, four sites, an E box, an AT-rich
element, a CACC sequence, and a CAGG motif, are also conserved in the
enhancer element of the quail TnIf gene (39, 61). In
addition, SURE contains a second AT-rich sequence and a bicoid
consensus site in its 5' end that are not present in FIRE. Mutations in
any of the conserved sites, with the exception of CACC, result in the
loss of muscle-specific SURE activity in adult mice, suggesting that
interactions among the factors binding to these sites might be
essential for its enhancer function. Moreover, since some of these
elements are present in both SURE and FIRE, the fiber-specific activity
is possibly controlled by the existence of distinct factors that
interact with the nonconserved regions within these enhancers.
The importance of the combinatorial involvement of some of these sites
in the regulation of many other skeletal muscle genes has been well
documented. In the quail TnIf IRE, which we refer to as FIRE, mutations
in any single element among the E-box, AT-rich, and CACC sequences
abrogate MyoD-induced enhancer activity in myofiber cell cultures
(39). The presence of CCAC and AT-rich elements was shown to
be essential for expression of the human myoglobin promoter in Sol8
myotubes (26). Similarly, the requirement for a novel site,
referred to as MEF-3, along with AT-rich MEF-2 and CACC elements, for
transcription of the slow/cardiac TnC gene (44) and of MEF-3
and MEF-2 for the regulation of rat aldolase distal promoter (pM)
activity (29) has been demonstrated in muscle cells.
However, evidence for the involvement of these elements in the
regulation of fiber-type-specific gene expression in the adult muscle
has not been established, although MEF-3 in conjunction with NFI was
implicated in the activity of rat aldolase pM in a subset of
fast-twitch muscles (54).
In order to characterize the discrete elements responsible for both the
myocyte-specific and the slow-twitch-fiber-specific activity of the
TnIs promoter in its chromatin context, we performed mutational
analyses of conserved and non-conserved regions of SURE in stably
transfected Sol8 myotubes and transgenic mice. Three elements that are
present in the 5' half of SURE, which we refer to as the A/T1,
bicoid-like, and CAGG motifs, were also shown to be necessary for the
muscle-specific activity of the enhancer (Fig. 3 and 7). Moreover,
since the deletion of these sites, along with CACC, from SURE
diminished enhancer activity only in stably transfected myocytes and
not in the transiently expressing cells (Fig. 5), this region might
play a critical role in establishing the open chromatin structure
needed for active transcription. In addition, the deleterious effect of
the A/T1 mutation in transgenic mice (Fig. 3) suggests that this site
and the sequences flanking it might be important for TnIs promoter activity during early development. Within this region, A/T1 and an
adjacent bicoid consensus site (GTTAATCCG) bind nuclear
proteins from Sol8 myotubes (see above and reference
9). Although the identity of the factor(s) binding
to these sequences is not established, recently a similar AT-rich
element in the murine IIB myosin heavy chain gene promoter, named mAT2
site, has been shown to bind Oct-1, a protein that contains a POU
binding domain (36). Similarly, sequences related to the
GTTAATCCG site, mutation of which results in the loss of
SURE activity in the stably transfected Sol8 myotubes (Fig. 4), have
been demonstrated to bind the bicoid subfamily of homeobox proteins in
Drosophila and mice (37, 40). Oct-1 and
bicoid-related proteins are suggested to play an important role in cell
lineage specification and pattern formation, respectively, during the
embryonic stages of development (11, 14, 21, 38).
Experiments involving the analysis of transgenes carrying bicoid site
mutations should help in the evaluation of the role of this sequence in
the fiber-type-specific expression of the TnIs promoter.
We could not detect any direct interaction between the CAGG sequence
and the nuclear extracts from myocytes, although this site is essential
for SURE activity in both myocytes and transgenic mice. It is possible
that this site interacts with complexes formed on other motifs in the
TnIs promoter, and thus the complexes bound to this sequence might not
be detected in the absence of those elements. Another possibility is
that the phosphorylation status of the protein(s) in the extract might
dictate its interaction with the CAGG element. Alternatively, this site
and the sequences flanking it might play an important role in the
chromatin remodeling mediated by the MyoD family of transcription
factors during myogenic lineage determination (22), a
hypothesis that is not inconsistent with the observation that E-box
mutations result in a complete loss of SURE activity (Fig. 2 and 3). A
possible requirement for interaction between the proximal sequences
(which include E-box and A/T2 elements) and the distal sequences (which
contain A/T1, bicoid consensus, and CAGG motifs) of SURE within the
chromosomal context is also indicated by the fact that the SURE
construct which includes only the proximal sequences is insufficient to support TnIs promoter activity in the stably transfected Sol8 myotubes
(Fig. 5B).
Since the interactions between the factors binding to multiple elements
within SURE are necessary for its function, it was important that the
order and spacing among these sites were preserved for further
characterization of fiber-type-specific regulatory elements in the TnIs
enhancer. Using a SURE-FIRE fusion construct, we have examined the role
that the E boxes present in SURE and FIRE play in the determination of
TnI expression in slow and fast muscles, respectively. Functional
differences among various E-box elements, based on variations both
within the consensus binding site and the flanking sequences, have been
demonstrated in the context of many other muscle-specific gene
promoters (1, 62). Differential expression of myogenic
factors that interact with E-box sequences has been demonstrated for
slow and fast muscles (32, 33, 57). In addition,
simultaneous mutation of three E boxes in the muscle creatine kinase
promoter reduce transcription in slow-twitch SOL but not in fast-twitch
skeletal muscles (53). Based on these findings, it has been
proposed that the bHLH factors may regulate the slow- and
fast-fiber-type-specific expression of the contractile genes in the
muscle (32, 33, 53). However, several lines of evidence that
indicated a negative correlation between the transcriptional activation
of these genes and the expression of bHLH factors in the skeletal
muscle have also been presented (8). Thus, in order to study
if the E-box elements of slow and fast TnI enhancers determined the
fiber type specificity of their respective promoters by virtue of their
ability to bind different bHLH factors, we analyzed the expression of
an E-box chimera in transgenic mice (Fig. 4). This construct, in which the E box within SURE was replaced with the equivalent sequence from
FIRE, was still transcriptionally active only in the slow-muscle fibers, similar to the wild-type TnI SURE, indicating that the FIRE E
box is able to functionally substitute for the SURE E element and that
the E box on its own cannot determine the fiber-type-specific activity
of the TnI enhancer sequences. These results are in agreement with the
observations that mutations of E-box sequences in the MLC1f/3f
(47) and aldolase A (50) promoters do not affect fiber-type-specific expression in transgenic mice.
Recently, Chin et al. (10) have shown that expression of the
human TnIs and myoglobin promoters in transfected cells is controlled
by the calcineurin- and NFAT-mediated signaling pathway. Based on their
results, it was proposed that the NFAT transcription factors regulate
slow-fiber-type specificity of muscle gene expression. However, as we
have shown in this study, a SURE-FIRE E-box chimera construct, in which
the NFAT site of SURE (
760/
753) is removed, continues to exhibit
slow-fiber-specific expression. In addition, FIRE, which contains at
least two consensus NFAT sites (+770/+763 and +756/+749), directs
fast-fiber-specific transcription and is not expressed in slow muscles.
The various analyses we have presented in this study, performed with
both myocytes and transgenic mice, provide strong evidence for the
conclusion that the interaction between factors binding to multiple
cis elements within SURE are essential for conferring
slow-fiber-type specificity to the TnIs promoter and that the
fiber-specific expression of SURE does not require the NFAT binding site.
 |
ACKNOWLEDGMENT |
We are grateful to Daniel Abebe for his expert technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unit on
Molecular Neurobiology, Building 49, Room 5A-38, 49 Convent Dr., MSC
4480, National Institutes of Health, Bethesda, MD 20892-4480. Phone: (301) 496-3298. Fax: (301) 496-9939. E-mail:
buonanno{at}helix.nih.gov.
 |
REFERENCES |
| 1.
|
Apone, S., and S. D. Hauschka.
1995.
Muscle gene E-box control elements. Evidence for quantitatively different transcriptional activities and the binding of distinct regulatory factors.
J. Biol. Chem.
270:21420-21427[Abstract/Free Full Text].
|
| 2.
|
Ausubel, F. M.
1992.
Short protocols in molecular biology: a compendium of methods from current protocols in molecular biology, 2nd ed.
Greene Publishing Associates, Brooklyn, N.Y.
|
| 3.
|
Banerjee-Basu, S., and A. Buonanno.
1993.
cis-acting sequences of the rat troponin I slow gene confer tissue- and development-specific transcription in cultured muscle cells as well as fiber type specificity in transgenic mice.
Mol. Cell. Biol.
13:7019-7028[Abstract/Free Full Text].
|
| 4.
|
Bassel-Duby, R.,
M. D. Hernandez,
Q. Yang,
J. M. Rochelle,
M. F. Seldin, and R. S. Williams.
1994.
Myocyte nuclear factor, a novel winged-helix transcription factor under both developmental and neural regulation in striated myocytes.
Mol. Cell. Biol.
14:4596-4605[Abstract/Free Full Text].
|
| 5.
|
Braun, T.,
G. Buschhausen-Denker,
E. Bober,
E. Tannich, and H. H. Arnold.
1989.
A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts.
EMBO J.
8:701-709[Medline].
|
| 6.
|
Braun, T.,
B. Winter,
E. Bober, and H. H. Arnold.
1990.
Transcriptional activation domain of the muscle-specific gene regulatory protein myf5.
Nature
346:663-665[Medline].
|
| 7.
|
Buckingham, M.
1992.
Making muscle in mammals.
Trends Genet
8:144-148[Medline].
|
| 8.
|
Buonanno, A., and N. Rosenthal.
1996.
Molecular control of muscle diversity and plasticity.
Dev. Genet.
19:95-107[Medline].
|
| 9.
|
Calvo, S.,
J. Stauffer,
M. Nakayama, and A. Buonanno.
1996.
Transcriptional control of muscle plasticity: differential regulation of troponin I genes by electrical activity.
Dev. Genet.
19:169-181[Medline].
|
| 10.
|
Chin, E. R.,
E. N. Olson,
J. A. Richardson,
Q. Yang,
C. Humphries,
J. M. Shelton,
H. Wu,
W. Zhu,
R. Bassel-Duby, and R. S. Williams.
1998.
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type.
Genes Dev.
12:2499-2509[Abstract/Free Full Text].
|
| 11.
|
Clark, M. E., and P. L. Mellon.
1995.
The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer.
Mol. Cell. Biol.
15:6169-6177[Abstract].
|
| 12.
|
Corin, S. J.,
O. Juhasz,
L. Zhu,
P. Conley,
L. Kedes, and R. Wade.
1994.
Structure and expression of the human slow twitch skeletal muscle troponin I gene.
J. Biol. Chem.
269:10651-10659[Abstract/Free Full Text].
|
| 13.
|
Corin, S. J.,
L. K. Levitt,
J. V. O'Mahoney,
J. E. Joya,
E. C. Hardeman, and R. Wade.
1995.
Delineation of a slow-twitch-myofiber-specific transcriptional element by using in vivo somatic gene transfer.
Proc. Natl. Acad. Sci. USA
92:6185-6189[Abstract/Free Full Text].
|
| 14.
|
Dailey, L.,
H. Yuan, and C. Basilico.
1994.
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.
Mol. Cell. Biol.
14:7758-7769[Abstract/Free Full Text].
|
| 15.
|
Davis, R. L.,
H. Weintraub, and A. B. Lassar.
1987.
Expression of a single transfected cDNA converts fibroblasts to myoblasts.
Cell
51:987-1000[Medline].
|
| 16.
|
Dignam, J. D.,
P. L. Martin,
B. S. Shastry, and R. G. Roeder.
1983.
Eukaryotic gene transcription with purified components.
Methods Enzymol.
101:582-598[Medline].
|
| 17.
|
Donoghue, M. J.,
J. P. Merlie,
N. Rosenthal, and J. R. Sanes.
1991.
Rostrocaudal gradient of transgene expression in adult skeletal muscle.
Proc. Natl. Acad. Sci. USA
88:5847-5851[Abstract/Free Full Text].
|
| 18.
|
Edmondson, D. G.,
T. C. Cheng,
P. Cserjesi,
T. Chakraborty, and E. N. Olson.
1992.
Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2.
Mol. Cell. Biol.
12:3665-3677[Abstract/Free Full Text].
|
| 19.
|
Edmondson, D. G., and E. N. Olson.
1989.
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.
Genes Dev.
3:628-640[Abstract/Free Full Text]. (Erratum 4:1450, 1990.)
|
| 20.
|
Emerson, C. P., Jr.
1993.
Skeletal myogenesis: genetics and embryology to the fore.
Curr. Opin. Genet. Dev.
3:265-274[Medline].
|
| 21.
|
Finkelstein, R., and N. Perrimon.
1990.
The orthodenticle gene is regulated by bicoid and torso and specifies Drosophila head development.
Nature
346:485-488[Medline]. (Comments.)
|
| 22.
|
Gerber, A. N.,
T. R. Klesert,
D. A. Bergstrom, and S. J. Tapscott.
1997.
Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis.
Genes Dev.
11:436-450[Abstract/Free Full Text].
|
| 23.
|
Gorman, C. M.,
L. F. Moffat, and B. H. Howard.
1982.
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Mol. Cell. Biol.
2:1044-1051[Abstract/Free Full Text].
|
| 24.
|
Gossett, L. A.,
D. J. Kelvin,
E. A. Sternberg, and E. N. Olson.
1989.
A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes.
Mol. Cell. Biol.
9:5022-5033[Abstract/Free Full Text].
|
| 25.
|
Graham, F. L., and A. J. Van der Eb.
1973.
A new technique for the assay of infectivity of human adenovirus 5 DNA.
Virology
52:456-467[Medline].
|
| 26.
|
Grayson, J.,
R. S. Williams,
Y. T. Yu, and R. Bassel-Duby.
1995.
Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter.
Mol. Cell. Biol.
15:1870-1878[Abstract].
|
| 27.
|
Hallauer, P. L.,
K. E. Hastings, and A. C. Peterson.
1988.
Fast skeletal muscle-specific expression of a quail troponin I gene in transgenic mice.
Mol. Cell. Biol.
8:5072-5079[Abstract/Free Full Text].
|
| 28.
|
Hastings, K. E.,
R. I. Koppe,
E. Marmor,
D. Bader,
Y. Shimada, and N. Toyota.
1991.
Structure and developmental expression of troponin I isoforms. cDNA clone analysis of avian cardiac troponin I mRNA.
J. Biol. Chem.
266:19659-19665[Abstract/Free Full Text].
|
| 29.
|
Hidaka, K.,
I. Yamamoto,
Y. Arai, and T. Mukai.
1993.
The MEF-3 motif is required for MEF-2-mediated skeletal muscle-specific induction of the rat aldolase A gene.
Mol. Cell. Biol.
13:6469-6478[Abstract/Free Full Text].
|
| 30.
|
Higuchi, R.
1990.
Recombinant PCR, p. 177-183.
In
M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols. A guide to methods and applications. Academic Press, San Diego, Calif.
|
| 31.
|
Hogan, B.
1994.
Manipulating the mouse embryo: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Plainview, N.Y.
|
| 32.
|
Hughes, S. M.,
K. Koishi,
M. Rudnicki, and A. M. Maggs.
1997.
MyoD protein is differentially accumulated in fast and slow skeletal muscle fibres and required for normal fibre type balance in rodents.
Mech. Dev.
61:151-163[Medline].
|
| 33.
|
Hughes, S. M.,
J. M. Taylor,
S. J. Tapscott,
C. M. Gurley,
W. J. Carter, and C. A. Peterson.
1993.
Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones.
Development
118:1137-1147[Abstract].
|
| 34.
|
Konieczny, S. F., and C. P. Emerson, Jr.
1987.
Complex regulation of the muscle-specific contractile protein (troponin I) gene.
Mol. Cell. Biol.
7:3065-3075[Abstract/Free Full Text].
|
| 35.
|
Kornhauser, J. M.,
D. E. Nelson,
K. E. Mayo, and J. S. Takahashi.
1992.
Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock.
Science
255:1581-1584[Abstract/Free Full Text].
|
| 36.
|
Lakich, M. M.,
T. T. Diagana,
D. L. North, and R. G. Whalen.
1998.
MEF-2 and oct-1 bind to two homologous promoter sequence elements and participate in the expression of a skeletal muscle-specific gene.
J. Biol. Chem.
273:15217-15226[Abstract/Free Full Text].
|
| 37.
|
Lamonerie, T.,
J. J. Tremblay,
C. Lanctot,
M. Therrien,
Y. Gauthier, and J. Drouin.
1996.
Ptx1, a bicoid-related homeobox transcription factor involved in transcription of the pro-opiomelanocortin gene.
Genes Dev.
10:1284-1295[Abstract/Free Full Text].
|
| 38.
|
Lanctot, C.,
B. Lamolet, and J. Drouin.
1997.
The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm.
Development
124:2807-2817[Abstract].
|
| 39.
|
Lin, H.,
K. E. Yutzey, and S. F. Konieczny.
1991.
Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors.
Mol. Cell. Biol.
11:267-280[Abstract/Free Full Text].
|
| 40.
|
Ma, X.,
D. Yuan,
K. Diepold,
T. Scarborough, and J. Ma.
1996.
The Drosophila morphogenetic protein Bicoid binds DNA cooperatively.
Development
122:1195-1206[Abstract].
|
| 41.
|
Miner, J. H., and B. Wold.
1990.
Herculin, a fourth member of the MyoD family of myogenic regulatory genes.
Proc. Natl. Acad. Sci. USA
87:1089-1093[Abstract/Free Full Text].
|
| 42.
|
Mulle, C.,
P. Benoit,
C. Pinset,
M. Roa, and J. P. Changeux.
1988.
Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells.
Proc. Natl. Acad. Sci. USA
85:5728-5732[Abstract/Free Full Text].
|
| 43.
|
Nakayama, M.,
J. Stauffer,
J. Cheng,
S. Banerjee-Basu,
E. Wawrousek, and A. Buonanno.
1996.
Common core sequences are found in skeletal muscle slow- and fast-fiber-type-specific regulatory elements.
Mol. Cell. Biol.
16:2408-2417[Abstract].
|
| 44.
|
Parmacek, M. S.,
H. S. Ip,
F. Jung,
T. Shen,
J. F. Martin,
A. J. Vora,
E. N. Olson, and J. M. Leiden.
1994.
A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle.
Mol. Cell. Biol.
14:1870-1885[Abstract/Free Full Text].
|
| 45.
|
Perrin, S., and G. Gilliland.
1990.
Site-specific mutagenesis using asymmetric polymerase chain reaction and a single mutant primer.
Nucleic Acids Res.
18:7433-7438[Abstract/Free Full Text].
|
| 46.
|
Pollock, R., and R. Treisman.
1991.
Human SRF-related proteins: DNA-binding properties and potential regulatory targets.
Genes Dev.
5:2327-2341[Abstract/Free Full Text].
|
| 47.
|
Rao, M. V.,
M. J. Donoghue,
J. P. Merlie, and J. R. Sanes.
1996.
Distinct regulatory elements control muscle-specific, fiber-type-selective, and axially graded expression of a myosin light-chain gene in transgenic mice.
Mol. Cell. Biol.
16:3909-3922[Abstract].
|
| 48.
|
Rhodes, S. J., and S. F. Konieczny.
1989.
Identification of MRF4: a new member of the muscle regulatory factor gene family.
Genes Dev.
3:2050-2061[Abstract/Free Full Text].
|
| 49.
|
Salminen, M.,
F. Spitz,
M. Y. Fiszman,
J. Demignon,
A. Kahn,
D. Daegelen, and P. Maire.
1995.
Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unknown proteins.
J. Mol. Biol.
253:17-31[Medline].
|
| 50.
|
Salminen, M.,
S. Lopez,
P. Maire,
A. Kahn, and D. Daegelen.
1996.
Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice.
Mol. Cell. Biol.
16:76-85[Abstract].
|
| 51.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 52.
|
Schiaffino, S., and C. Reggiani.
1996.
Molecular diversity of myofibrillar proteins: gene regulation and functional significance.
Physiol. Rev.
76:371-423[Abstract/Free Full Text].
|
| 53.
|
Shield, M. A.,
H. S. Haugen,
C. H. Clegg, and S. D. Hauschka.
1996.
E-box sites and a proximal regulatory region of the muscle creatine kinaes gene differentially regulate expressioni in diverse skeletal muscle and cardiac muscle of transgenic mice.
Mol. Cell. Biol.
16:5058-5068[Abstract].
|
| 54.
|
Spitz, F.,
M. Salminen,
J. Demignon,
A. Kahn,
D. Daegelen, and P. Maire.
1997.
A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles.
Mol. Cell. Biol.
17:656-666[Abstract].
|
| 55.
|
Stanojevic, D.,
S. Small, and M. Levine.
1991.
Regulation of a segmentation stripe by overlapping activators and repressors in the Drosophila embryo.
Science
254:1385-1387[Abstract/Free Full Text].
|
| 56.
|
Sugden, B.,
K. Marsh, and J. Yates.
1985.
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
Mol. Cell. Biol.
5:410-413[Abstract/Free Full Text].
|
| 57.
|
Voytik, S. L.,
M. Przyborski,
S. F. Badylak, and S. F. Konieczny.
1993.
Differential expression of muscle regulatory factor genes in normal and denervated adult rat hindlimb muscles.
Dev. Dyn.
198:214-224[Medline].
|
| 58.
|
Weintraub, H.,
R. Davis,
S. Tapscott,
M. Thayer,
M. Krause,
R. Benezra,
T. K. Blackwell,
D. Truner,
R. Rupp,
S. Hollenberg, et al.
1991.
The myoD gene family: nodal point during specification of the muscle cell lineage.
Science
251:761-766[Abstract/Free Full Text].
|
| 59.
|
Wright, W. E.,
D. A. Sassoon, and V. K. Lin.
1989.
Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.
Cell
56:607-617[Medline].
|
| 60.
|
Yu, Y. T.,
R. E. Breitbart,
L. B. Smoot,
Y. Lee,
V. Mahdavi, and B. Nadal-Ginard.
1992.
Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.
Genes Dev.
6:1783-1798[Abstract/Free Full Text].
|
| 61.
|
Yutzey, K. E.,
R. L. Kline, and S. F. Konieczny.
1989.
An internal regulatory element controls troponin I gene expression.
Mol. Cell. Biol.
9:1397-1405[Abstract/Free Full Text].
|
| 62.
|
Yutzey, K. E., and S. F. Konieczny.
1992.
Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer.
Nucleic Acids Res.
20:5105-5113[Abstract/Free Full Text].
|
| 63.
|
Zot, A. S., and J. D. Potter.
1987.
Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction.
Annu. Rev. Biophys. Biophys. Chem.
16:535-559[Medline].
|
Molecular and Cellular Biology, January 1999, p. 515-525, Vol. 19, No. 1
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rana, Z. A., Gundersen, K., Buonanno, A.
(2008). Activity-dependent repression of muscle genes by NFAT. Proc. Natl. Acad. Sci. USA
105: 5921-5926
[Abstract]
[Full Text]
-
Vissing, K., McGee, S. L., Roepstorff, C., Schjerling, P., Hargreaves, M., Kiens, B.
(2008). Effect of sex differences on human MEF2 regulation during endurance exercise. Am. J. Physiol. Endocrinol. Metab.
294: E408-E415
[Abstract]
[Full Text]
-
Pregelj, P., Trinkaus, M., Zupan, D., Trontelj, J. J., Sketelj, J.
(2007). The Role of Muscle Activation Pattern and Calcineurin in Acetylcholinesterase Regulation in Rat Skeletal Muscles. J. Neurosci.
27: 1106-1113
[Abstract]
[Full Text]
-
Tidball, J. G.
(2005). Mechanical signal transduction in skeletal muscle growth and adaptation. J. Appl. Physiol.
98: 1900-1908
[Abstract]
[Full Text]
-
Rana, Z. A, Gundersen, K., Buonanno, A., Vullhorst, D.
(2005). Imaging transcription in vivo: distinct regulatory effects of fast and slow activity patterns on promoter elements from vertebrate troponin I isoform genes. J. Physiol.
562: 815-828
[Abstract]
[Full Text]
-
Salerno, M. S., Thomas, M., Forbes, D., Watson, T., Kambadur, R., Sharma, M.
(2004). Molecular analysis of fiber type-specific expression of murine myostatin promoter. Am. J. Physiol. Cell Physiol.
287: C1031-C1040
[Abstract]
[Full Text]
-
McCullagh, K. J. A., Calabria, E., Pallafacchina, G., Ciciliot, S., Serrano, A. L., Argentini, C., Kalhovde, J. M., Lomo, T., Schiaffino, S.
(2004). NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc. Natl. Acad. Sci. USA
101: 10590-10595
[Abstract]
[Full Text]
-
Mann, K. M., Ray, J. L., Moon, E. S., Sass, K. M., Benson, M. R.
(2004). Calcineurin initiates smooth muscle differentiation in neural crest stem cells. JCB
165: 483-491
[Abstract]
[Full Text]
-
Nguyen, Q.-G. V., Buskin, J. N., Himeda, C. L., Shield, M. A., Hauschka, S. D.
(2003). Differences in the Function of Three Conserved E-boxes of the Muscle Creatine Kinase Gene in Cultured Myocytes and in Transgenic Mouse Skeletal and Cardiac Muscle. J. Biol. Chem.
278: 46494-46505
[Abstract]
[Full Text]
-
Polly, P., Haddadi, L. M., Issa, L. L., Subramaniam, N., Palmer, S. J., Tay, E. S. E., Hardeman, E. C.
(2003). hMusTRD1{alpha}1 Represses MEF2 Activation of the Troponin I Slow Enhancer. J. Biol. Chem.
278: 36603-36610
[Abstract]
[Full Text]
-
Hogan, P. G., Chen, L., Nardone, J., Rao, A.
(2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev.
17: 2205-2232
[Full Text]
-
Neal, J. W., Clipstone, N. A.
(2003). A Constitutively Active NFATc1 Mutant Induces a Transformed Phenotype in 3T3-L1 Fibroblasts. J. Biol. Chem.
278: 17246-17254
[Abstract]
[Full Text]
-
Tsika, R. W., McCarthy, J., Karasseva, N., Ou, Y., Tsika, G. L.
(2002). Divergence in species and regulatory role of beta -myosin heavy chain proximal promoter muscle-CAT elements. Am. J. Physiol. Cell Physiol.
283: C1761-C1775
[Abstract]
[Full Text]
-
Horsley, V., Pavlath, G. K.
(2002). Nfat: ubiquitous regulator of cell differentiation and adaptation. JCB
156: 771-774
[Abstract]
[Full Text]
-
Calvo, S., Vullhorst, D., Venepally, P., Cheng, J., Karavanova, I., Buonanno, A.
(2001). Molecular Dissection of DNA Sequences and Factors Involved in Slow Muscle-Specific Transcription. Mol. Cell. Biol.
21: 8490-8503
[Abstract]
[Full Text]
-
Allen, D. L., Sartorius, C. A., Sycuro, L. K., Leinwand, L. A.
(2001). Different Pathways Regulate Expression of the Skeletal Myosin Heavy Chain Genes. J. Biol. Chem.
276: 43524-43533
[Abstract]
[Full Text]
-
Liu, Y., Cseresnyes, Z., Randall, W. R., Schneider, M. F.
(2001). Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers. JCB
155: 27-40
[Abstract]
[Full Text]
-
Torgan, C. E., Daniels, M. P.
(2001). Regulation of Myosin Heavy Chain Expression during Rat Skeletal Muscle Development In Vitro. Mol. Biol. Cell
12: 1499-1508
[Abstract]
[Full Text]
-
Spangenburg, E. E., Williams, J. H., Roy, R. R., Talmadge, R. J.
(2001). Skeletal muscle calcineurin: influence of phenotype adaptation and atrophy. Am. J. Physiol. Regul. Integr. Comp. Physiol.
280: R1256-R1260
[Abstract]
[Full Text]
-
Shuler, C.F., Dalrymple, K.R.
(2001). Molecular Regulation of Tongue and Craniofacial Muscle Differentiation. CROBM
12: 3-17
[Abstract]
[Full Text]
-
Swoap, S. J., Hunter, R. B., Stevenson, E. J., Felton, H. M., Kansagra, N. V., Lang, J. M., Esser, K. A., Kandarian, S. C.
(2000). The calcineurin-NFAT pathway and muscle fiber-type gene expression. Am. J. Physiol. Cell Physiol.
279: C915-C924
[Abstract]
[Full Text]
-
Kaffer, C. R., Srivastava, M., Park, K.-Y., Ives, E., Hsieh, S., Batlle, J., Grinberg, A., Huang, S.-P., Pfeifer, K.
(2000). A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev.
14: 1908-1919
[Abstract]
[Full Text]
-
Hallauer, P. L., Karpati, G., Hastings, K. E. M.
(2000). Skeletal muscle gene transfer: regeneration-associated deregulation of fast troponin I fiber type specificity. Am. J. Physiol. Cell Physiol.
278: C1266-C1274
[Abstract]
[Full Text]
-
Naya, F. J., Mercer, B., Shelton, J., Richardson, J. A., Williams, R. S., Olson, E. N.
(2000). Stimulation of Slow Skeletal Muscle Fiber Gene Expression by Calcineurin in Vivo. J. Biol. Chem.
275: 4545-4548
[Abstract]
[Full Text]
-
Mitchell-Felton, H., Hunter, R. B., Stevenson, E. J., Kandarian, S. C.
(2000). Identification of Weight-bearing-responsive Elements in the Skeletal Muscle Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA1) Gene. J. Biol. Chem.
275: 23005-23011
[Abstract]
[Full Text]
-
Horsley, V., Pavlath, G. K.
(2002). Nfat: ubiquitous regulator of cell differentiation and adaptation. JCB
156: 771-774
[Abstract]
[Full Text]
-
Hallauer, P. L., Hastings, K. E. M.
(2002). Coregulation of fast contractile protein transgene and glycolytic enzyme expression in mouse skeletal muscle. Am. J. Physiol. Cell Physiol.
282: C113-C124
[Abstract]
[Full Text]